Written answers
Tuesday, 9 October 2018
Department of Health
Rare Diseases
Michael Harty (Clare, Independent)
Link to this: Individually | In context | Oireachtas source
344. To ask the Minister for Health the progress of the rare diseases medical product technology review committee; the drugs that have been referred to it by the HSE; the way in which it is scheduling or prioritising the review of each drug; the number of drugs it expects to review in 2018; the timelines associated with reviewing medicines; and if he will make a statement on the matter. [41125/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As the question refers to the National Rare Disease Technology Review Committee it has been referred to the HSE for direct reply to the Deputy.
No comments